These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31508602)

  • 1. An Analysis of Resistance Patterns of Oral Streptococci Obtained from Orofacial Infections Against Beta-lactams, Clindamycin and Vancomycin over 2014-2018.
    Leszczynski P; Sokol-Leszczynska B; Mlynarczyk A; Sawicka-Grzelak A; Mlynarczyk G
    Oral Health Prev Dent; 2019; 17(6):585-589. PubMed ID: 31508602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial susceptibility of some streptococci strains of anginosus group isolated from oral and maxillofacial infections.
    Băncescu G; Skaug N; Dumitriu S; Băncescu A
    Roum Arch Microbiol Immunol; 1999; 58(1):57-63. PubMed ID: 11845446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the MicroScan MICroSTREP plus antimicrobial panel for testing β-hemolytic streptococci and viridans group streptococci.
    Kim SJ; Uh Y; Jang IH; Lee KS; Park SD; Yoon KJ
    Korean J Lab Med; 2011 Jul; 31(3):185-90. PubMed ID: 21779193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility patterns of beta-hemolytic and viridans group streptococci: report from the SENTRY Antimicrobial Surveillance Program (1997-2000).
    Gordon KA; Beach ML; Biedenbach DJ; Jones RN; Rhomberg PR; Mutnick AH
    Diagn Microbiol Infect Dis; 2002 Jun; 43(2):157-62. PubMed ID: 12088624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility of viridans group streptococci.
    Tuohy M; Washington JA
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):277-80. PubMed ID: 9458986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nosocomial streptococcal blood stream infections in the SCOPE Program: species occurrence and antimicrobial resistance. The SCOPE Hospital Study Group.
    Pfaller MA; Jones RN; Marshall SA; Edmond MB; Wenzel RP
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):259-63. PubMed ID: 9458983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence rate and antibiotic susceptibility of oral viridans group streptococci (VGS) in healthy children population.
    Rozkiewicz D; Daniluk T; Sciepuk M; Zaremba ML; Cylwik-Rokicka D; Luczaj-Cepowicz E; Milewska R; Marczuk-Kolada G; Stokowska W
    Adv Med Sci; 2006; 51 Suppl 1():191-5. PubMed ID: 17460837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility against penicillin, ampicillin and vancomycin of viridans group Streptococcus in oral microbiota of patients at risk of infective endocarditis.
    Süzük S; Kaşkatepe B; Çetin M
    Infez Med; 2016 Sep; 24(3):190-3. PubMed ID: 27668898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB; Fernandes LA; Fernandes CJ
    Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Identification and antibiotic susceptibility of viridans group streptococci isolates recovered from patients hospitalized at a teaching hospital in Buenos Aires City].
    Heine AC; García S; Barberis C; Vay C; E Mollerach M; Bonofiglio L; Famiglietti Á
    Rev Argent Microbiol; 2019; 51(1):26-31. PubMed ID: 29941157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral streptococcal strains isolated from odontogenic infections and their susceptibility to antibiotics.
    Bancescu G; Dumitriu S; Bancescu A; Pana M; Andrei M
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(4):1012-5. PubMed ID: 17438917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population structure and characterization of viridans group streptococci (VGS) isolated from the upper respiratory tract of patients in the community.
    Nakajima T; Nakanishi S; Mason C; Montgomery J; Leggett P; Matsuda M; Coulter WA; Millar BC; Goldsmith CE; Moore JE
    Ulster Med J; 2013 Sep; 82(3):164-8. PubMed ID: 24505152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythromycin and penicillin resistance mechanisms among viridans group streptococci isolated from blood cultures of adult patients with underlying diseases.
    Ergin A; Eser ÖK; Hasçelik G
    New Microbiol; 2011 Apr; 34(2):187-93. PubMed ID: 21617831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dalbavancin in-vitro activity obtained against Gram-positive clinical isolates causing bone and joint infections in US and European hospitals (2011-2016).
    Pfaller MA; Flamm RK; Castanheira M; Sader HS; Mendes RE
    Int J Antimicrob Agents; 2018 Apr; 51(4):608-611. PubMed ID: 29277526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF).
    Maeda Y; Elborn JS; Parkins MD; Reihill J; Goldsmith CE; Coulter WA; Mason C; Millar BC; Dooley JS; Lowery CJ; Ennis M; Rendall JC; Moore JE
    J Cyst Fibros; 2011 Mar; 10(2):133-9. PubMed ID: 21145793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America.
    Diekema DJ; Beach ML; Pfaller MA; Jones RN;
    Clin Microbiol Infect; 2001 Mar; 7(3):152-7. PubMed ID: 11318814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs.
    Traub WH; Leonhard B
    Chemotherapy; 1997; 43(1):10-20. PubMed ID: 8996736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative activity and spectrum of broad-spectrum beta-lactams (cefepime, ceftazidime, ceftriaxone, piperacillin/tazobactam) tested against 12,295 staphylococci and streptococci: report from the SENTRY antimicrobial surveillance program (North America: 2001-2002).
    Fritsche TR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2003 Oct; 47(2):435-40. PubMed ID: 14522519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter evaluation of the BD Phoenix Automated Microbiology System for antimicrobial susceptibility testing of Streptococcus species.
    Richter SS; Howard WJ; Weinstein MP; Bruckner DA; Hindler JF; Saubolle M; Doern GV
    J Clin Microbiol; 2007 Sep; 45(9):2863-71. PubMed ID: 17652483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).
    Tazumi A; Maeda Y; Goldsmith CE; Coulter WA; Mason C; Millar BC; McCalmont M; Rendall J; Elborn JS; Matsuda M; Moore JE
    J Antimicrob Chemother; 2009 Sep; 64(3):501-6. PubMed ID: 19584106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.